FDA.reportPublic FDA data

DermaClear BHA Spot Treatment

Manufacturer
Allure Labs
Effective date
2024-12-05
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 00:41:03

Label at a glance#

ProductDermaClear BHA Spot Treatment
Active ingredientSALICYLIC ACID
Label structure10 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient: Salicylic Acid - 2%

OTC - PURPOSE SECTION

Purpose: Acne Treatment

INDICATIONS & USAGE SECTION

Uses:

  • For the treatment of acne.

WARNINGS SECTION

Warnigs

  • For external use only

OTC - WHEN USING SECTION

When using this product

  • Avoid contact with eyes, lips and mouth.
  • Using other topical acne medication at the same time ot immefiately following use of this product may increase dryness or irritation of the skin. If this occurs only one medication should be used unless directed by a doctor.
  • If sensitive to the sun or when increased sun exposure is expected use a sunscreen.

OTC - STOP USE SECTION

Stop use and ask a doctor:

  • If severe skin irritation occurs.
  • Using other topical medication at the same time

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children:

  • If swallowed, get medical help or contact a Poison Control Centre right away.

DOSAGE & ADMINISTRATION SECTION

Directions

  • Apply a small portion over the affected area with finger tips and gently massage onto the skin.
  • Reapply as needed.

INACTIVE INGREDIENT SECTION

Other ingredients:

Water (aqua), SD Alcohol 40-B, Butylene Glycol, Hydroxypropylcellulose

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Manufactured For Dermaquest ®, Inc.

Hayward, CA 94544

1272 GK, NL Made in USA

dermaquestinc.com

IMGDQIDBHASTIMGDQIDBHAST

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62742-4195-1DermaClear BHA Spot Treatment4.8 g in 1 BOTTLE, WITH APPLICATORGEL4.82
62742-4195-2DermaClear BHA Spot Treatment1 in 1 CARTONGEL12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
62742-4195DERMACLEAR BHA SPOT TREATMENT (SALICYLIC ACID) GEL [ALLURE LABS]2Current NDC, Legacy NDC, 2 package rows20241208_b629cb05-548e-4d60-e053-2a95a90aeefb.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
62742-419562742-4195-1, 62742-4195-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
NameUNIIKind
WATER059QF0KO0RIACT
HYDROXYPROPYL CELLULOSE, UNSPECIFIED9XZ8H6N6OHIACT
SALICYLIC ACIDO414PZ4LPZACTIB
ALCOHOL3K9958V90MIACT
BUTYLENE GLYCOL3XUS85K0RAIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DermaClear BHA Spot TreatmentSALICYLIC ACIDAllure Labsb629cb05-548e-4d60-e053-2a95a90aeefb2024-12-05WarningsExact identifier
ndc (package): 62742-4195-2
ndc (package): 62742-4195-1
ndc (product): 62742-4195
ndc11 (package): 62742419501
ndc11 (package): 62742419502
spl id: 288f04bb-1a27-2b88-e063-6394a90a3b3c
spl set id: b629cb05-548e-4d60-e053-2a95a90aeefb

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.